REFERENCES
- Sester M, Sester U, Clauer P, . Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int. 2004;65:1826–1834.
- Hamilton CD. Infectious complications of treatment with biologic agents. Curr Opin Rheumatol. 2004;16:393–398.
- American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:221–247.
- Chia S, Karim M, Elwood RK, FitzGerald JM. Risk of tuberculosis in dialysis patients: A population-based study. Int J Tuberc Lung Dis. 1998;2:989–991.
- Andrew OT, Schoenfeld PY, Hopewell PC, Humphreys MH. Tuberculosis in patients with end-stage renal disease. Am J Med. 1980;68:59–65.
- Poduval R, Hammes MD. Tuberculosis screening in dialysis patients—Is the tuberculin test effective? Clin Nephrol. 2003;59:436–440.
- Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest. 1998;113:25–27.
- Malone RS, Fish DN, Spiegel DM, Childs JM, Peloquin CA. The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol. Am J Respir Crit Care Med. 1999;159:1580–1584.
- Murthy BVR, Pereira BJG. A1990s perspective of hepatitis C, human immunodeficiency virus and tuberculosis infections in dialysis patients. Semin Nephrol. 1997;17:346–363.
- Chou KJ, Fang HC, Bai KJ, Hwang SJ, Yang WC, Chung HM. Tuberculosis in maintenance dialysis patients. Nephron. 2001;88:138–143.
- Ahmed AT, Karter AJ. Tuberculosis in California dialysis patients. Int J Tuberc Lung Dis. 2004;8:341–345.
- Tuberculosis transmission in a renal dialysis center—Nevada. 2003. MMWR Morb Mortal Wkly Rep. 2004;53(37):873–875.
- Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial. 2003;16:38–44.
- Chan TY. Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int. 2000;66:476–478.
- Tzanno-Martins C, Futata E, Jorgetti V, Duarte AJS. Restoration of impaired T-cell proliferation after parathyroidectomy in hemodialysis patients. Nephron 2000;84:224–227.
- Abdelrahman M, Sinha AK, Karkar A. Tuberculosis in end stage renal disease patients on hemodialysis. Hemodial Int. 2006;10:360–364.
- Wauters A, Peetermans WE, Van den Brande P, . The value of tuberculin skin testing in hemodialysis patients. Nephrol Dial Transplant. 2004;19:433–438.
- Rutsky EA, Rostand SG. Mycobacteriosis in patients with chronic renal failure. Arch Intern Med. 1980;140:57–61.
- Korzets A, Gafter U. Tuberculosis prophylaxis for the chronically dialysed patient—Yes or no? Nephrol Dial Transplant. 1999;14:2857–2859.
- Erkoc R, Dogan E, Sayarlioglu H, . Tuberculosis in dialysis patients, single centre experience from an endemic area. Int J Clin Pract. 2004;58:1115–1117.
- Alvarez S, McCabe WR. Extrapulmonary tuberculosis revisited: A review of experience at Boston City and other hospitals. Medicine 1984;63:25–55.
- Fang HC, Chou KJ, Chen CL, . Tuberculin skin test and anergy in dialysis patients of the tuberculosis endemic area. Nephron 2002;91:682–687.
- Ko YC, Lee CT, Cheng YF, . Hypercalcemia and hemophagocytic syndrome: Rare concurrent presentations of disseminated tuberculosis in a dialysis patient. Int J Clin Pract. 2004;58:723–725.
- Woeltje KF, Mathew A, Rothstein M, Seiler S, Fraser VJ. Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis. 1998;31:848–852.
- Hussein MM, Bakir N, Roujouleh H. Tuberculosis in patients undergoing maintenance dialysis. Nephrol Dial Trans. 1990;5:584–587.
- Ozkara S, Aktas Z, Ozkan S, . Türkiye’de Tüberkülozun Kontrolü İçin Başvuru Kitabı, Türkiye’de durum. Ankara. 2003;9–10.
- Passalent L, Khan K, Richardson R, . Detecting latent tuberculosis infection in hemodialysis patients: A head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol. 2003;2:68–73.
- Choudhury D, Salazar CL. Preventive health care in chronic kidney disease and end-stage renal disease. Nat Clin Pract Nephrol. 2008;4:194–206.
- National Kidney Foundation. KDOQI clinical practice guidelines for hemodialysis adequacy, 2000. Am J Kidney Dis. 2001;37(suppl. 1):S7–S64.
- Lo WK, Ho YW, Li CS, et al. Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int. 2003;64:649–656.
- Habesoglu MA, Torun D, Demiroglu YZ, . Value of the tuberculin skin test in screening for tuberculosis in dialysis patients. Renal Fail. 2005;27:425–428.
- Taskapan H, Oymak O, Utas C. Tuberculin and anergy testing in CAPD patients. Perit Dial Int. 2000;2:807–809.
- Dogan E, Erkoc R, Sayarlioglu H, Uzun K. Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients. Renal Fail. 2005;27:425–428.
- Agarwal SK, Gupta S, Bhowmik D, Mahajan S. Tuberculin skin test for the diagnosis of latent tuberculosis during renal replacement therapy in an endemic area: A single center study. Indian J Nephrol. 2010;20:132–136.
- Christopoulos AI, Diamantopoulos AA, Dimopoulos PA, Goumenos DS, Barbalias GA. Risk factors for tuberculosis in dialysis patients: A prospective multi-center clinical trial. BMC Nephrol. 2009;10:36.
- Aydoğan O, Gürgün A, Başoğlu OK, . Tuberculin skin test reactivity in patients with chronic renal failure. Tuberk Toraks. 2009;57:268–276.
- Angelini D, Carlini A, Mazzotta L, . Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy. Clin Nephrol. 1994;42:246–250.
- Angelini D, Carlini A, Giusti R, . Parathyroid hormone and T-cellular immunity in uremic patients in replacement dialytic therapy. Artif Organs. 1993;17:73–75.
- Griveas I, Visvardis G, Papadopoulou D, . Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis. Renal Fail. 2005;27:275–278.